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Summary 
The injection into the rat of 8.1 mmoles of aminoendo(±)-2- 
aminobicycloheptane-2-carboxylic acid per kg body weight intensi- 
fied in 2 hr the gradients of several System L substrates charac- 
teristically maintained by the liver with respect to the blood 
plasma. The gradients of amino acids predominantly transported 
by systems other than L were not, with the exception of proline, 
significantly influenced. We interpret this effect on System L 
substrates as supporting the principal service of System L in net 
cellular exodus of these amino acids, although other factors in 
the effects are not necessarily excluded. 
In our earlier tests by administering non-metabolizable analogs on the dis- 
tribution of the amino acids in the rat (i), we had expected perturbations of 
only one kind. We predicted decreases, not increases, to arise through the com- 
petitive action of the artificial amino acid on the ability of tissues to main- 
tain normal concentrations of certain groups of amino acids in relation to theil 
plasma levels. And those were in general the results we observed (i). But our 
protocols reveal retrospectively an opposite effect which we have now come to 
understand and expect, namely intensified hepatic gradients of certain amino 
acids 2 hr after injecting the norbornane amino acid "BCH" (the aminoendo(±) 
isomer of 2-aminobicyclo-(2,2,1)heptane-2-carboxylic acids). On the basis of 
experiments with Ehrlich ascites tumor cells, we have concluded that the amino 
acids transported especially by System L nevertheless undergo their net concen- 
trative uptake mainly by the steeply uphill System A. Nevertheless these amino 
acids maintain only moderate intracellular:extracellular gradients we believe 
because in the physiological context System L comes to serve mainly for their 
net exodus (2). Accordingly, an effect of excess BCH as an apparently specific 
System L inhibitor not to perturb the distribution of the amino acids transpor- 
ted mainly by System A, but instead to intensify the gradients maintained for a 
group of amino acids with longer, branched sidechains of low polarity, becomes 
logical and the first good evidence for in UiVo operation of the cycle, net cel- 
lular entrance by A and net exodus by L. 
Methods 
The norbornane amino acid, our own preparation (3,4) was injected intra- 
peritoneally, 8.1 mmoles per kg body weight, into male Sprague-Dawley rats 
weighing 250 to 350 g. Food had been withheld 18 to 20 hr before the injection, 
and the liver removed, killing the animal. The tissues were analyzed as de- 
scribed previously (i), applying automated ion-exchange chromatography for the 
amino acids. Control rats received an injection of isotonic NaCl in the corre- 
sponding volume. The conditions of adrenalectomy were as described previously 
(1). 
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Experimental Results 
Fig. 1 shows that BCH injection produced in 2 hr no significant changes in 
the distribution ratio between liver and plasma for aspartate, glutamate, 
threonine, serine, the sum of asparagine plus glutamine, glycine, tyrosine, 
phenylalanine, lysine or histidine. The amino acids strongly affected were 
alanine, valine, methionine, isoleucine, leucine, ornithine and proline. Their 
gradients were in all cases raised. We find immediately logical the inclusion 
of the first 5 of the latter group of amino acids, all with apolar sidechains 
and showing substantial BCH-inhibitable, Na+-independent uptake in isolated rat 
hepatocytes, i.e. uptake by System L (5,6). Proportional transport of alanine 
by System L into hepatocytes can exceed that by System A (Table II, ref. 7). 
The observation that phenylalanine and tyrosine escape the effect do~ not agree 
with the role accorded System L for these two aromatic amino acids in various 
other cells (see ref. 6). Therefore this result has set us to looking for a 
contribution by a possible aromatic transport system which may have been hereto- 
fore overlooked. Evidence for independently regulated intestinal absorption of 
these two amino acids has been reported (8). The sensitivity of the ornithine 
distribution could arise from the circumstance that the cationic amino acid 
transport system can scarcely be detected in isolated hepatocytes (M. F. White, 
doctoral thesis in preparation), a circumstance that might leave much of the 
in vitro uptake of ornithine to System L, for which ornithine can become a sub- 
strate by deprotonation to a dipolar form, as reported earlier for the Ehrlich 
cell (9,10). The present finding may mean that System L serves more for hepa- 
tic exodus than uptake of ornithine in the fasting rat. The position of pro- 
line in the list of responsive amino acids remains unexplained, but might be a 
result of its generation from ornithine at a rate sufficient to cause accumula- 
tion. These paradoxes mean that some of the effects may have alternative ex- 
planations. We plan to turn to a homologous metabolism-resistant model sub- 
strate for System L that fails to stimulate insulin release. 
System L of the rat liver has so far shown no obvious point of difference 
from the corresponding system as originally described in the Ehrlich cell (6). + 
BCH shows a rapid uptake, with no apparent Na -dependent component when initial 
rates are approached (5). BCH inhibits the uptake by the hepatocyte of the + 
various amino acids otherwise known to be transported by System L, and not Na - 
dependent components of amino acid uptake (5). Exchange by this system is as in 
most other cases lively (unpublished result, R. Garcia-Ca~ero, this laboratory). 
The uptake of BCH by the liver of the intact rat (ii) or by the perfused liver 
(12) is not stimulated by insulin or glucagon. Various experiments have shown 
System L of hepatocytes likewise insensitive to these hormones (e.g. 13). BCH 
uptake has not been found to be stimulated by amino acid starvation, nor does 
BCH repress transport by System A (14). 
The administration of BCH does stimulate the pancreatic release of insulin 
in the rat (15-19) (also in other species), a discovery made in the course of 
the present research, and one which in fact drew our attention away from imme- 
diate efforts to understand the results reported here. This action now appears 
to arise from a stimulation of glutamate dehydrogenase by BCH (19). It is con- 
ceivable that an elevation of the plasma insulin could have stimulated somewhat 
the hepatic uptake of the amino acids listed between threonine and alanine in 
Fig. i, i.e., via System A. Such a hypothetical effect could have masked pos- 
sible minor inhibition of the tissue retention of some of these amino acids by 
BCH, and intensified the gradients maintained for proline and alanine. Since 
System L is not stimulated by insulin, however, insulin release seems unlikely 
to have been a factor in the intensified gradients for valine, methionine, iso- 
leucine, leucine and ornithine. Because we recognized that adrenal cortical 
steroid release after BCH injection might occur to modify amino acid distribu- 
tion secondarily, we confirmed that the characteristic effects of BCH injection 
were also obtained in adrenalectomized rats (Fig. i) . The BCH effects tended 
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FIG. i 
Effect of intraperitoneal BCH on the distribution of amino acids between the 
liver and the plasma. The points -, e, and x represent by their position rela 
tive to the ordinate scale the percent of the control distribution ratio for 
the designated amino acid observed in an experimental rat, as in our preceding 
study (i). The vertical solid lines represent the range for the gradients of 
a given amino acid found for three or more control rats, the mean value having 
been normalized to 100% for each amino acid. The points • represent the mean 
ratios observed for the intact BCH-treated rats, four animals in each case. 
The vertical dashed lines show the range through which these results varied 
among the animals. The number adjoining the point, •, represents the mean 
absolute hepatic concentration (not the gradient) found for that amino acid, 
as percent of the mean control concentration. Control amino acid levels, 
mmol/kg liver cell water ± standard deviation, 5 rats, from which other concen 
trations can be reconstructed: Asp 2.54 ± 0.63; Thr, 048 ± 0.07; Set 
0.67 i 0.19; Asn+ Gln 1.39 ± 0.61; Glu 1.56 i 0.61; Pro 0.24 ± 0.065; Gly 
3.84 ± 0.61; Ala 2.29 ± 0.43; Val 0.42 i 0.115; Met 0.16 ± 0.035; Ile 0.27 ± 
0.07; Leu 0.50 ± 0.15; Tyr 0.15 ± 0.05; Phe 0.19 ± 0.06; Orn 0.093 i 0.035; 
Lys 1.06 ± 0.18; His 0.69 i 0.13. The mean BCH levels in mmoles/liter water 
were i0.i, liver cells, and 7.1, plasma. Five mmoles BCH/kg body weight also 
increased the liver to plasma distribution ratio for alanine, valine, isoleu- 
cine and leucine, whereas a 1 mmole dose produced only questionable increases. 
The points, x, represent the gradients of the amino acid produced by 8.1 
mmoles BCH in two adrenalectomized rats, compared with two adrenalectomized 
controls. The four numbers at the top, center, represent some gradients, as 
percent of controls, which rose beyond the ordinate scale. We can illustrate 
the foregoing interpretation of the figure using valine, approximately at the 
center of the figure. The gradient for this amino acid has been elevated 
significantly by a mean of 53%, this increase being due more to a fall in 
plasma valine than to a rise of hepatic valine (the latter by an average of 
12%). In our interpretation, for a compartment relatively as large as the 
hepatic one, one expects modifications of uphill transport to be reflected 
more by plasma changes than by changes in the liver level. The hepatic valine 
gradient was increased even more in two adrenalectomized animals. Interpreta- 
tion for the other amino acids follows the same lines as this example. 
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rather to be strengthened, as though they might have been opposed to a degree 
by adrenal cortical activity in the intact animals. The BCH-induced increase 
in the gradient for glycine, associated mainly with a decline in its plasma 
level and seen only in the two adrenalectomized rats, remains unexplained. 
Support for the concept that amino acid distribution can be selectively 
modified by metabolism-resistant transport analogs comes from the consistent 
action in the reverse direction produced by injection of 2-aminoisobutyric acid 
in the same study (i), which effect came to be restricted to the notable System 
A substrates when the more specific System A substrate, 2-(methylamino)isobutyr 
ic acid (5,20) was substituted for its close analog lacking the N-methyl group. 
An incidental question raised by those earlier results becomes steadily more 
interesting: Accepting that the facilities for regulation of cellular amino 
acid levels are conspicuous and vital (21,22), we wonder how the young growing 
rat can tolerate as well as it does an approximate aggregate halving on 3 weeks 
AIB feeding, of its hepatic amino acid levels or gradients (i). 
The above results show how unwise it would be to ignore the role of trans- 
port systems other than L in considering the distribution of the so-called 
"System L substrates". When System L is largely blocked, we may see how large 
a part is played in their distribution by other agencies, presumably System A 
in particular. The possibility developed here that amino acid gradients may be 
intensified, rather than decreased, by interference with a transport system 
probably also deserves increased attention. 
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